BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20036953)

  • 1. Homocysteine, vitamin determinants and neurological diseases.
    Ientile R; Curro' M; Ferlazzo N; Condello S; Caccamo D; Pisani F
    Front Biosci (Schol Ed); 2010 Jan; 2(1):359-72. PubMed ID: 20036953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke: roles of B vitamins, homocysteine and antioxidants.
    Sánchez-Moreno C; Jiménez-Escrig A; Martín A
    Nutr Res Rev; 2009 Jun; 22(1):49-67. PubMed ID: 19555518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chapter 30: historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():445-76. PubMed ID: 19892133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-vitamins, homocysteine metabolism and CVD.
    Strain JJ; Dowey L; Ward M; Pentieva K; McNulty H
    Proc Nutr Soc; 2004 Nov; 63(4):597-603. PubMed ID: 15831132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations].
    Herrmann W; Lorenzl S; Obeid R
    Fortschr Neurol Psychiatr; 2007 Sep; 75(9):515-27. PubMed ID: 17729191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-vitamins, homocysteine and gene polymorphism in adults with fasting or post-methionine loading hyperhomocysteinemia.
    Cheng CH; Huang YC; Chen FP; Chou MC; Tsai TP
    Eur J Nutr; 2008 Dec; 47(8):491-8. PubMed ID: 18979127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nutritional determinants of homocysteinemia].
    Krajcovicová-Kudlácková M; Blazícek P
    Cas Lek Cesk; 2002 Jul; 141(13):417-20. PubMed ID: 12238029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of hyperhomocysteinemia as a risk factor for diseases: an overview.
    Herrmann W
    Clin Chem Lab Med; 2001 Aug; 39(8):666-74. PubMed ID: 11592431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Public health control of hyperhomocysteinemia and its consequences].
    Czeizel E; Kalina A
    Orv Hetil; 2003 Oct; 144(40):1981-9. PubMed ID: 14626640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High plasma homocysteine: a risk factor for vascular disease in the elderly.
    Moustapha A; Robinson K
    Coron Artery Dis; 1998; 9(11):725-30. PubMed ID: 9919419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of homocysteine in age-related vascular and non-vascular diseases.
    Parnetti L; Bottiglieri T; Lowenthal D
    Aging (Milano); 1997 Aug; 9(4):241-57. PubMed ID: 9359935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate and homocysteine.
    Young IS; Woodside JV
    Curr Opin Clin Nutr Metab Care; 2000 Nov; 3(6):427-32. PubMed ID: 11085827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on cobalamin, folate, and homocysteine.
    Carmel R; Green R; Rosenblatt DS; Watkins D
    Hematology Am Soc Hematol Educ Program; 2003; ():62-81. PubMed ID: 14633777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties.
    Cacciapuoti F
    J Thromb Thrombolysis; 2011 Jul; 32(1):82-8. PubMed ID: 21234645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction.
    Ciaccio M; Bellia C
    Curr Clin Pharmacol; 2010 Feb; 5(1):30-6. PubMed ID: 20236081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview.
    Castro R; Rivera I; Blom HJ; Jakobs C; Tavares de Almeida I
    J Inherit Metab Dis; 2006 Feb; 29(1):3-20. PubMed ID: 16601863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
    Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
    Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
    Green TJ; Skeaff CM; McMahon JA; Venn BJ; Williams SM; Devlin AM; Innis SM
    Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.